Abstract
The amyloid β-peptide (Aβ) and aluminum have been found, among other components, in the senile plaques from Alzheimer’s disease patients. Aggregated Aβ and aluminum are toxic to neurons but the mechanism of accumulation and toxicity remains poorly understood. It has been proposed that Aβ and aluminum toxicity results from Aβ– and aluminum–membrane interactions. For this reason it was thought of interest to study the effect that Aβ and aluminum could have on cell membranes. With this aim, Aβ(1–40), Aβ(1–42), and Al(III) were incubated with intact human erythrocytes, isolated unsealed human erythrocyte membranes (IUM), and molecular models of the erythrocyte membrane. These consisted in bilayers of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), phospholipids classes located in the outer and inner monolayers of the erythrocyte membrane, respectively. Their capacity to perturb the bilayer structures of DMPC and DMPE was assessed by X-ray diffraction, IUM were studied by fluorescence spectroscopy, and intact human erythrocytes were observed by scanning electron microscopy (SEM). It was found that Aβ(1–40) and Aβ(1–42) in the presence of Al(III) altered the erythrocyte morphology, in IUM induced an ordering effect at the bilayer hydrophobic region, and the structure of DMPC bilayers was perturbed, effects that were different and stronger of those induced by each Aβ and Al(III) separately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Aβ:
-
β-amyloid peptides
- DMPC:
-
Dimyristoylphosphatidylcholine
- DMPE:
-
Dimyristoylphosphatidylethanolamine
- DPH:
-
1,6-Diphenyl-1,3,5-hexatriene
- GP:
-
Generalized polarization
- IUM:
-
Isolated unsealed human erythrocyte membranes
- laurdan:
-
6-Dodecanoyl-2-dimethylaminonaphtalene
- r :
-
Anisotropy
- SEM:
-
Scanning electron microscopy
References
Eckert GP, Wood WG, Muller WE (2001) Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes. J Neural Transm 108:1051–1064
Eckert GP, Wood WG, Muller WE (2005) Membrane disordering effects of beta-amyloid peptides. Subcell Biochem 38:319–337
Lau TL, Ambroggio EE, Tew DJ, Cappai R, Masters CL, Fidelio GD, Barnham KJ, Separovic F (2005) Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions. J Mol Biol 356:759–770
Demeester N, Baier G, Enzinger C, Goethals M, Vandekerckhove J, Rosseneu M, Labeur C (2000) Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes. Mol Membr Biol 17:219–228
Ambroggio EE, Kim DH, Separovic F, Barrow CJ, Barnham KJ, Bagatolli LA, Fidelio GD (2005) Surface behavior and lipid interaction of Alzheimer beta-amyloid peptide 1-42: a membrane-disrupting peptide. Biophys J 88:2706–2713
Mason RP, Jacob RF, Walter MF, Mason PE, Avdulov NA, Chochina SV, Wood WG (1999) Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes. J Biol Chem 274:18801–18807
Shin RW, Lee VM, Trojanowski JQ (1994) Aluminum modifies the properties of Alzheimer’s disease PHF tau proteins in vivo and in vitro. J Neurosci 14(Pt 2):7221–7233
Waschuk SA, Elton EA, Darabie AA, Fraser PE, McLaurin JA (2001) Cellular membrane composition defines A beta-lipid interactions. J Biol Chem 276:33561–33568
McLaurin J, Chakrabartty A (1997) Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur J Biochem 245:355–363
Muller WE, Kirsch C, Eckert GP (2001) Membrane-disordering effects of beta-amyloid peptides. Biochem Soc Trans 29(Pt 4):617–623
Yokel RA (2000) The toxicology of aluminum in the brain: a review. Neurotoxicology 21:813–828
Jansson ET (2001) Aluminum exposure and Alzheimer’s disease. J Alzheimers Dis 3:541–549
Rondeau V (2002) A review of epidemiologic studies on aluminum and silica in relation to Alzheimer’s disease and associated disorders. Rev Environ Health 17:107–121
Zatta P, Kiss T, Suwalsky M, Bretón M (2002) Aluminum(III) as promoter of cellular oxidation. Coord Chem Rev 228:271–284
Zatta P, Lucchini R, van Rensburg SJ, Taylor A (2003) The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 62:15–28
Exley C, Korchazhkina O (2001) The association of aluminium and β amyloid in Alzheimer’s disease. In: Exley C (ed) Aluminium and Alzheimer’s disease. Elsevier, Amsterdam, p 421
Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, Ravid R, Jagannatha Rao KS (2005) Aluminium in Alzheimer’s disease: are we still at a crossroad? Cell Mol Life Sci 62:143–158
Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Roher AE (2000) Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun 268:750–756
Jayakumar R, Kusiak JW, Chrest FJ, Demehin AA, Murali J, Wersto RP, Rifkind JM (2003) Red cell perturbations by amyloid beta-protein. Biochim Biophys Acta 1622:20–28
Mattson MP, Begley JG, Mark RJ, Furukawa K (1997) Abeta25-35 induces rapid lysis of red blood cells: contrast with Abeta1-42 and examination of underlying mechanisms. Brain Res 771:147–153
Mark RJ, Hensley K, Butterfield DA, Mattson MP (1995) Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J Neurosci 15:6239–6249
Goodall HB, Reid AH, Findlay DJ, Hind C, Kay J, Coghill G (1994) Irregular distortion of the erythrocytes (acanthocytes, spur cells) in senile dementia. Dis Markers 12:23–41
Devaux PF, Zachowsky A (1994) Distribution of phospholipids in erythrocyte membranes. Chem Phys Lipids 73:107–120
Boon JM, Smith BD (2002) Chemical control of phospholipid distribution across bilayer membranes. Med Res Rev 22:251–281
Suwalsky M, Villena F, Norris B, Cuevas YF, Sotomayor CP, Zatta P (2003) Effects of lead on the human erythrocyte membrane and molecular models. J Inorg Biochem 97:308–313
Suwalsky M, Villena F, Norris B, Cuevas F, Sotomayor CP (2004) Cadmium-induced changes in the membrane of human erythrocytes and molecular models. J Inorg Biochem 98:1061–1066
Suwalsky M, Zambenedetti P, Carpene E, Ibnlkayat M, Wittkowski W, Messori L, Zatta P (2004) Effects of chronic treatment with sodium tetrachloroaurate(III) in mice and membrane models. J Inorg Biochem 98:2080–2086
Suwalsky M, Villena F, Norris B, Soto MA, Sotomayor CP, Messori L, Zatta P (2005) Structural effects of titanium citrate on the human erythrocyte membrane. J Inorg Biochem 99:764–770
Suwalsky M, Martinez F, Cardenas H, Grzyb J, Strzalka K (2005) Iron affects the structure of cell membrane molecular models. Chem Phys Lipids 134:69–77
Suwalsky M, Castro R, Villena F, Sotomayor CP (2008) Cr(III) exerts stronger structural effects than Cr(VI) on the human erythrocyte membrane and molecular models. J Inorg Biochem 102:842–849
Suwalsky M, Novoa V, Villena F, Sotomayor CP, Aguilar LF, Ronowska A, Szutowicz A (2009) Structural effects of Zn(2+) on cell membranes and molecular models. J Inorg Biochem 103:797–804
Parasassi T, Gratton E (1995) Membrane lipid domains and dynamics as detected by laurdan fluorescence, J. Fluoresc. 5: 59–69.
Dodge JT, Mitchell C, Hanahan DJ (1963) The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 100:119–30
Lakowicz JR (1999) Principles of Fluorescence Spectroscopy, Plenum
Parasassi T, De Stasio G, D’Ubaldo A, Gratton E (1990) Phase fluctuation in phospholipid membranes revealed by laurdan fluorescence, Biophys. J. 57:1179–1186.
Suwalsky M (1996) Phospholipids bilayers. In: Salamone JC (ed) Polymeric materials encyclopedia, vol 7. CRC, Boca Raton, FL, p 5073
Sheetz MP, Singer SJ (1974) Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc Natl Acad Sci USA 71:4457–4461
MacKinnon N, Ridgway J, Crowell KJ, Macdonald PM (2006) Aluminum binding to phosphatidylcholine lipid bilayer membranes: aluminum exchange lifetimes from 31P NMR spectroscopy. Chem Phys Lipids 139:85–95
Vyas SB, Duffy LK (1995) Interaction of synthetic Alzheimer beta-protein-derived analogs with aqueous aluminum: a low-field 27Al NMR investigation. J Protein Chem 14:633–644
Pillot T, Goethals M, Vanloo B, Talussot C, Brasseur R, Vandekerckhove J, Lins L (1996) Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J Biol Chem 271:28757–28765
Curtain CC, Ali FE, Smith DG, Bush AI, Masters CL, Barnham KJ (2003) Metal ions, pH, and cholesterol regulate the interactions of Alzheimer’s disease amyloid-beta peptide with membrane lipid. J Biol Chem 278:2977–2982
Drago D, Folin M, Baiguera S, Tognon G, Ricchelli F, Zatta P (2007) Comparative effects of Abeta(1-42)-Al complex from rat and human amyloid on rat endothelial cell cultures. J Alzheimers Dis 11:33–44
Acknowledgements
The authors thank Fernando Neira for his valuable technical assistance. This work was supported by a grant from FONDECYT (1090041).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Wien
About this chapter
Cite this chapter
Suwalsky, M., Hernandez, P.L., Sotomayor, C.P. (2012). Aluminum increases toxic effects of amyloid β-peptides on the human erythrocyte membrane and molecular models. In: Linert, W., Kozlowski, H. (eds) Metal Ions in Neurological Systems. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1001-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1001-0_11
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1000-3
Online ISBN: 978-3-7091-1001-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)